Contribution of CsrR-Regulated Virulence Factors to the Progress and Outcome of Murine Skin Infections by Streptococcus pyogenes

ABSTRACT Streptococcus pyogenes with null mutations in the csrRS regulatory locus are highly virulent in mice due to derepression of hyaluronic acid capsule synthesis and exotoxins, e.g., streptolysin S (SLS) and pyrogenic exotoxin B (SpeB). We generated derivatives of a ΔcsrRS strain that also carry deletions in hasAB (leading to an acapsular phenotype) or in sagA (phenotypically SLS−) or an interruption of speB (SpeB−) to test the relative contributions of these factors to the development of necrotic skin lesions. Inoculation of 2 × 106 to 4 × 106 CFU of either acapsular or SLS− strains into hairless mice resulted in lesions ∼70% smaller than those of the ΔcsrRS parent strain. Elimination of SLS also reduced lethality from 100% to 0% at this inoculum (P < 10−7; Fisher exact test). In contrast, SLS+ SpeB− mutants yielded lesions that were only 41% smaller than the parent strain (t = 2.2; P = 0.04), but only 3 the 17 lesions had dermal sloughing (P = 10−5). The nonulcerative lesions associated with SpeB− strains appeared pale with surrounding erythema. We conclude that capsule and SLS contribute to the subcutaneous spread of S. pyogenes and to a fatal outcome of infection. SpeB facilitates early dermal ulceration but has minor influence on lesion size and mortality. Large ulcerative lesions are observed only when both toxins are present.

[1]  J. Musser,et al.  Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Yutsudo,et al.  Cysteine Protease Activity and Histamine Release from the Human Mast Cell Line HMC-1 Stimulated by Recombinant Streptococcal Pyrogenic Exotoxin B/Streptococcal Cysteine Protease , 2002, Infection and Immunity.

[3]  V. Nizet,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[4]  M. Wessels,et al.  Group A Streptococcus tissue invasion by CD44-mediated cell signalling , 2001, Nature.

[5]  M. Wessels,et al.  Absence of a Cysteine Protease Effect on Bacterial Virulence in Two Murine Models of Human Invasive Group A Streptococcal Infection , 2001, Infection and Immunity.

[6]  M. Boyle,et al.  Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. , 2001, The Journal of infectious diseases.

[7]  V. DiRita,et al.  Identification of a major, CsrRS-regulated secreted protein of Group A streptococcus. , 2001, Microbial pathogenesis.

[8]  V. DiRita,et al.  Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. , 2001, The Journal of infectious diseases.

[9]  J. Musser,et al.  Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. , 2001, The Journal of infectious diseases.

[10]  A. Podbielski,et al.  The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin‐binding and cysteine protease activity , 2001, Molecular microbiology.

[11]  E. Hanski,et al.  Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. , 2000, The Journal of infectious diseases.

[12]  J. Musser,et al.  Identification and Immunogenicity of Group AStreptococcus Culture Supernatant Proteins , 2000, Infection and Immunity.

[13]  Malak Kotb,et al.  Inverse Relation between Disease Severity and Expression of the Streptococcal Cysteine Protease, SpeB, among Clonal M1T1 Isolates Recovered from Invasive Group A Streptococcal Infection Cases , 2000, Infection and Immunity.

[14]  I. Stamenkovic,et al.  CD44 as a receptor for colonization of the pharynx by group A Streptococcus. , 2000, The Journal of clinical investigation.

[15]  D. Bessen,et al.  Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci , 2000, Molecular microbiology.

[16]  V. Nizet,et al.  Genetic Locus for Streptolysin S Production by Group A Streptococcus , 2000, Infection and Immunity.

[17]  J. McNiff,et al.  Humanized In Vivo Model for Streptococcal Impetigo , 2000, Infection and Immunity.

[18]  V. DiRita,et al.  A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenesVirulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B , 1999, Infection and Immunity.

[19]  I. Ginsburg,et al.  Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae? , 1999, FEMS immunology and medical microbiology.

[20]  M. Federle,et al.  A Response Regulator That Represses Transcription of Several Virulence Operons in the Group A Streptococcus , 1999, Journal of bacteriology.

[21]  M. Wessels,et al.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus , 1998, Molecular microbiology.

[22]  P. Tsai,et al.  Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection , 1998, Infection and Immunity.

[23]  M. Wessels,et al.  Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. , 1998, The Journal of clinical investigation.

[24]  D. Low,et al.  Reduced Virulence of Group A Streptococcal Tn916 Mutants That Do Not Produce Streptolysin S , 1998, Infection and Immunity.

[25]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[26]  M. Wessels,et al.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.

[27]  A. M. Marciel,et al.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease , 1996, Infection and immunity.

[28]  L. Björck,et al.  Streptococcal cysteine proteinase releases kinins: a virulence mechanism , 1996, The Journal of experimental medicine.

[29]  J. Musser,et al.  Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. , 1994, The Journal of biological chemistry.

[30]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[31]  E. Maguin,et al.  An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature‐sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes , 1993, Molecular microbiology.

[32]  D. Musher,et al.  Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). , 1993, The Journal of infectious diseases.

[33]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[34]  R. Higuchi 22 – RECOMBINANT PCR , 1990 .

[35]  J. Alouf,et al.  Production, purification, and assay of streptolysin S. , 1988, Methods in enzymology.

[36]  R. Schwartz,et al.  Immunologic abnormalities in HRS/J mice. I. Specific deficit in T lymphocyte helper function in a mutant mouse. , 1980, Journal of immunology.

[37]  A. Reske-Kunz,et al.  Disproportion in T-cell subpopulations in immunodeficient mutant hr/hr mice , 1979, The Journal of experimental medicine.